Below is a list of peer-reviewed publications by PGXL Laboratories Lab staff. Where possible, links to those publications are included.

  1. Keeling KL, Linder MW., Bukaveckas BL, Jortani SA., Valdes R Jr. A Rigorous Approach For Investigation of Unexpected Phenytoin Toxicity. J Clin Ligand Assay 2003 (in print)
  2. Linder MW, Valdes R, Jr. Genetic mechanisms for variability in drug response and toxicity. J Anal Toxicol 2001;25:405-13.
  3. Linder MW, Bosse GM, Henderson MT, Midkiff G, Valdes R. Detection of cocaine metabolite in serum and urine: frequency and correlation with medical diagnosis. Clin Chim Acta 2000;295:179-85.
  4. Linder MW, Valdes R, Jr. Pharmacogenetics in the practice of laboratory medicine. Mol Diagn 1999;4:365-79.
  5. Cao Z, Linder MW, Jevans AW, Brown G, Valdes R, Jr. Comparison of tacrolimus concentrations measured by the IMx tacrolimus II vs the PRO-TRAC II FK506 ELISA assays. Clin Chem 1999;45:1868-70.
  6. Linder MW, Valdes R, Jr. Fundamentals and applications of pharmacogenetics for the clinical laboratory. Ann Clin Lab Sci 1999;29:140-9.
  7. Linder MW, Prough RA, Valdes R, Jr. Pharmacogenetics: a laboratory tool for optimizing therapeutic efficiency. Clin Chem 1997;43:254-66.
  8. Linder MW, Valdes R, Jr. Mechanism and elimination of aspirin-induced interference in Emit II d.a.u. assays. Clin Chem 1994;40:1512-6.
  9. Wagener RE, Linder MW, Valdes R, Jr. Decreased signal in Emit assays of drugs of abuse in urine after ingestion of aspirin: potential for false-negative results. Clin Chem 1994;40:608-12.